Peter F. Thall
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Optimal Experimental Design Methods, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,047 cited
- → Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002(2007)725 cited
- → Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation(2001)570 cited
- → Dose‐Finding Based on Efficacy–Toxicity Trade‐Offs(2004)501 cited
- → Some Covariance Models for Longitudinal Count Data with Overdispersion(1990)468 cited
- → Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer(2013)460 cited